8-K - Atossa Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Securities Modification

Charter Amendment

Exhibits

Disclosure

Mandatory

Variant

8-K

Items Reported

3.03

. Material Modification to Rights of Security Holders. Following the Special Meeting, the Company’s Board of Directors approved a reverse stock split (the “Reve

Securities Modification

5.03

. Item 5.07. Submission of Matters to a Vote of Security Holders. As of the close of business on December 19, 2025, the record date for the Special Meeting, the

Charter Amendment

9.01

Financial Statements and Exhibits (d) Exhibits Exhibit Number Description of Exhibit 3.1 Certificate of Amendment to the Amended and Restated Certificate of Inc

Exhibits Only

Exhibits (2)

3.1

EX-3.1

8-K